Gairdner Foundation To Honor Biomedical Engineer, Four Others

For the first time in almost 40 years of recognizing outstanding contributions to medical science, the Gairdner Foundation of Willowdale, Ontario, Canada, will honor the growing field of biomedical engineering. Robert Langer, a biomedical engineer from the Massachusetts Institute of Technology who has made landmark discoveries in drug delivery, is one of five researchers who will be presented with the foundation's annual International Awards at a ceremony on October 25 in Toronto. "When I star

Written byKaren Young Kreeger
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

For the first time in almost 40 years of recognizing outstanding contributions to medical science, the Gairdner Foundation of Willowdale, Ontario, Canada, will honor the growing field of biomedical engineering. Robert Langer, a biomedical engineer from the Massachusetts Institute of Technology who has made landmark discoveries in drug delivery, is one of five researchers who will be presented with the foundation's annual International Awards at a ceremony on October 25 in Toronto.

"When I started doing [the drug-delivery] work in the 1970s, people in chemical engineering and biomedical engineering thought it was on the fringe, at best," recalls Langer. "Now it's something they're very proud of."

Since its inception in 1957, the foundation has honored 243 scientists. Of these honorees, 46 -- or almost 20 percent -- have gone on to win a Nobel Prize. The five winners for 1996, each of whom will receive $30,000 in Canadian funds ($21,900 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies